David E. Hurtado, Ph.D.
Affiliations: | 2011 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
tau, dementia, neurodegenerationGoogle:
"David Hurtado"Mean distance: 16.53 (cluster 24) | S | N | B | C | P |
Parents
Sign in to add mentor| Virginia Man-Yee Lee | grad student | 2011 | Penn | |
| (Selective reduction of GSK-3 isoforms ameliorates pathological signatures of Alzheimer's disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hurtado DE, Molina-Porcel L, Carroll JC, et al. (2012) Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7392-402 |
| Cohen TJ, Guo JL, Hurtado DE, et al. (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nature Communications. 2: 252 |
| Hurtado DE, Molina-Porcel L, Iba M, et al. (2010) A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. The American Journal of Pathology. 177: 1977-88 |